January 2004

J Psychiatry Neurosci 2004;29(1)

Editorial

Does lithium save lives?
R.T. Joffe

Review papers

The role of indoleamine 2,3-dioxygenase (IDO) in the pathophysiology of interferon-α-induced depression
M.C. Wichers, M. Maes

Eating disorders and the serotonin connection: state, trait and developmental effects
H. Steiger

Research Papers

Immediate effects of risperidone on cerebral activity in healthy subjects: a comparison with subjects with first-episode schizophrenia
C.J. Lane, E.T.C. Ngan, L.N. Yatham, T.J. Ruth, P.F. Liddle

Heroin and cocaine co-use in a group of injection drug users in Montréal
F. Leri, J. Stewart, A. Tremblay, J. Bruneau

The physician-scientist in Canadian psychiatry
W.G. Honer, M.A. Linseman

Brief Report

Olanzapine in the treatment of pervasive developmental disorders: a case series analysis
C. Stavrakaki, R. Antochi, P.C. Emer

CCNP News and Views

The 27th Annual Meeting of the Canadian College of Neuropsychopharmacology Kingston, Ontario, Canada, May 29–June 1, 2004

Reviewers

Reviewers

March 2004

J Psychiatry Neurosci 2004;29(2)

Editorial

What exactly is a mood stabilizer?
L.T. Young

Review papers

Semantics and N400: insights for schizophrenia
N. Kumar, J.B. Debruille

Should cognitive deficit be a diagnostic criterion for schizophrenia?
R. Lewis

Research Papers

Orphanin FQ/nociceptin suppresses motor activity through an action along the mesoaccumbens axis in rats
S. Narayanan, H. Lam, F.I. Carroll, K. Lutfy

Antidepressant-like activity of S 20098 (agomelatine) in the forced swimming test in rodents: involvement of melatonin and serotonin receptors
M. Bourin, E. Mocaër, R. Porsolt

Brief Report

Eating disorders with binge-eating behaviour are associated with the s allele of the 3′-UTR VNTR polymorphism of the dopamine transporter gene
M. Shinohara, H. Mizushima, M. Hirano, K. Shioe, M. Nakazawa, Y. Hiejima, Y. Ono, S. Kanba

Cotard’s syndrome with schizophreniform disorder can be successfully treated with electroconvulsive therapy: case report
O. Caliyurt, E. Vardar, C. Tuglu

CCNP News and Views

The 27th Annual Meeting of the Canadian College of Neuropsychopharmacology Kingston, Ontario, Canada, May 29–June 1, 2004

Psychopharmacology for the Clinician

What are the diagnostic criteria, therapy and prophylaxis for discontinuation symptoms due to SSRIs?
T. Higuchi

May 2004

J Psychiatry Neurosci 2004;29(3)

Editorial

Neurobiology of severe mental disorders: from cell to bedside 25th International Symposium of the Centre de recherche en sciences neurologiques, Université de Montréal
P.P. Rompré, E. Stip, L.E. Trudeau

CRSN Symposium: Focus on Depression, Part I

Gene-environment interaction and the genetics of depression
K.P. Lesch

Implication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depression
N. Barden

Implications of adult hippocampal neurogenesis in antidepressant action
J.E. Malberg

Impact of substance P receptor antagonism on the serotonin and norepinephrine systems: relevance to the antidepressant/anxiolytic response
P. Blier, G. Gobbi, N. Haddjeri, L. Santarelli, G. Mathew, R. Hen

CCNP News and Views

The 27th Annual Meeting of the Canadian College of Neuropsychopharmacology Kingston, Ontario, Canada, May 29-June 1, 2004

Psychopharmacology for the Clinician

What is the role of pharmacotherapy in tobacco cessation in patients with schizophrenia?
C. Els

July 2004

 J Psychiatry Neurosci 2004;29(4)

Editorial

How many good antidepressant medications have we missed?
P. Blier

CRSN Symposium: Focus on Depression, Part II

The therapeutic role of 5-HT1A and 5-HT2A receptors in depression
P. Celada, M.V. Puig, M. Amargós-Bosch, A. Adell, F. Artigas

Transcranial magnetic stimulation (TMS) of the human frontal cortex: implications for repetitive TMS treatment of depression
T. Paus, J. Barrett

CRSN Symposium: Focus on Schizophrenia

Using animal models to test a neurodevelopmental hypothesis of schizophrenia
B.K. Lipska

Postmortem investigations of the pathophysiology of schizophrenia: the role of susceptibility genes
W.R. Perlman, C.S. Weickert, M. Akil, J.E. Kleinman

Glutamate co-transmission as an emerging concept in monoamine neuron function
L.É. Trudeau

CCNP News and Views

Canadian College of Neuropsychopharmacology 2004 Award Winners

September 2004

J Psychiatry Neurosci 2004;29(5)

Editorial

Ethical conduct of journal editors
S.N. Young, R.T. Joffe

Commentary

Glyceraldehyde-3-phosphate dehydrogenase as a target for small-molecule disease-modifying therapies in human neurodegenerative disorders
M.D. Berry

Review Papers

Implication des gènes du système sérotoninergique dans la vulnérabilité aux conduites suicidaires
P. Courtet, F. Jollant, D. Castelnau, B. Astruc, C. Buresi, A. Malafosse

Mother to infant or infant to mother? Reciprocal regulation of responsiveness to stress in rodents and the implications for humans
C.D. Walker, S. Deschamps, K. Proulx, M. Tu, C. Salzman, B. Woodside, S. Lupien, N. Gallo-Payet, D. Richard

Research Paper

Peripheral thyroid hormones and response to selective serotonin reuptake inhibitors
M. Gitlin, L.L. Altshuler, M.A. Frye, R. Suri, E.L. Huynh, L. Fairbanks, M. Bauer, S. Korenman

CCNP News and Views

American Psychiatric Association honours founding member of the Canadian College of Neuropsychopharmacology

Psychopharmacology for the Clinician

With all the recent concern about SSRIs and suicidality, what advice should be given to the practising clinician regarding the management of a depressed young person?
Y.D. Lapierre

November 2004

J Psychiatry Neurosci 2004;29(6)

Editorial

Nitric oxide: A key player in the relation between cardiovascular disease and major depressive disorder?
J.M. Le Mellédo, N. Mahil, G.B. Baker

Review Papers

The role of the hippocampus in the pathophysiology of major depression
S. Campbell, G. MacQueen

Interactions between ß-amyloid and central cholinergic neurons: implications for Alzheimer’s disease
S. Kar, S.P.M. Slowikowski, D. Westaway, H.T.J. Mount

Research Paper

Testing the association between thyroid dysfunction and psychiatric diagnostic group in an iodine-deficient area
D. Hermann, W. Hewer, F. Lederbogen

Potential benefits of quetiapine in the treatment of substance dependence disorders
S.P Sattar, S.C. Bhatia, F. Petty

Valproic acid inhibits corticotropin-releasing factor synthesis and release from the rat hypothalamus in vitro: evidence for the involvement of GABAergic neurotransmission
G. Tringali, J.M. Aubry, K. Moscianese, C. Zamori, M. Vairano, P. Preziosi, P. Navarra, G. Pozzoli

Brief Report

Tardive dyskinesia in 2 patients treated with ziprasidone
J. Ananth, K.S. Burgoyne, D. Niz, M. Smith

CCNP News and Views

The 27th Annual Meeting of the Canadian College of Neuropsychopharmacology, Kingston, Ontario, Canada, May 29 to June 1, 2004
C. Flores, T. Paine, L.K. Srivastava, M. Leyton

Psychopharmacology for the Clinician

Although antidepressants and anxiolytics are frequently used together to treat depression in the acute phase, how effective is the concomitant use of these drugs?
S. Kanba

January 2005

J Psychiatry Neurosci 2005;30(1)

Editorial

Depression and multiple sclerosis: a potential way to understand the biology of major depressive illness
R.T. Joffe

Research Papers

The effects of nefazodone on women with seasonal affective disorder: clinical and polysomnographic analyses
J. Shen, S.H. Kennedy, R.D. Levitan, L. Kayumov, C.M. Shapiro

Increased occipital delta dipole density in major depressive disorder determined by magnetoencephalography
A. Fernández, A. Rodriguez-Palancas, M. López-Ibor, P. Zuluaga, A. Turrero, F. Maestú, C. Amo, J.J. López-Ibor Jr., T Ortiz

Is initiation of smoking associated with the prodromal phase of schizophrenia?
K. Riala, H. Hakko, M. Isohanni, A. Pouta, P. Räsänen

Adult metachromatic leukodystrophy: disorganized schizophrenia-like symptoms and postpartum depression in 2 sisters
H. Gregoric Kumperscak, E. Paschke, P. Gradisnik, J. Vidmar, S. Umek Bradac

Information-processing deficits and cognitive dysfunction in panic disorder
S. Ludewig, M.A. Geyer, M. Ramseier, F.X. Vollenweider, E. Rechsteiner, K. Cattapan-Ludewig

The effect of methionine and S-adenosylmethionine on S-adenosylmethionine levels in the rat brain
S.N. Young, M. Shalchi

Brief Report

Preliminary evidence for an association between aggression and hostile behaviour and 3α,5α-tetrahydroprogesterone plasma levels in schizophrenia
G. Spalletta, E. Romeo, G. Bonaviri, G. Bernardi, C. Caltagirone, F. di Michele

Object versus spatial visual mental imagery in patients with schizophrenia
A. Aleman, E.H.F. de Haan, R.S. Kahn

Letter to the Editors

Quetiapine-induced hypothyroidism
S. Ramaswamy, Z. Siddiqui, S. Saharan, T.L. Gabel, S.C. Bhatia Reviewers

Reviewers

Reviewers

Psychopharmacology for the Clinician

What is the optimal implementation of bright light therapy for seasonal affective disorder (SAD)?
Robert D. Levitan

March 2005

J Psychiatry Neurosci 2005;30(2)

Editorial

Repetitive transcranial magnetic stimulation for the treatment of depression: To stimulate or not to stimulate?
Z.J. Daskalakis

Review Papers

Efficacy of rapid-rate repetitive transcranial magnetic stimulation in the treatment of depression: a systematic review and meta-analysis
J.L. Couturier

A framework for targeting alternative brain regions with repetitive transcranial magnetic stimulation in the treatment of depression
D.J.L.G. Schutter, J. van Honk

Research Papers

Methylphenidate hydrochloride improves cognitive function in patients with advanced cancer and hypoactive delirium: a prospective clinical study
B. Gagnon, G. Low, G. Schreier

Changes in 5-HT1A receptor binding and G-protein activation in the rat brain after estrogen treatment: comparison with tamoxifen and raloxifene
M. Le Saux, T. Di Paolo

Perinatal complications in children with attention-deficit hyperactivity disorder and their unaffected siblings
L. Ben Amor, N. Grizenko, G. Schwartz, P. Lageix, C. Baron, M. Ter-Stepanian, M. Zappitelli, V. Mbekou, R. Joober

Cortical hyperexcitability in post-traumatic stress disorder secondary to minor accidental head trauma: a neurophysiologic study
D. Centonze, M.G. Palmieri, L. Boffa, M. Pierantozzi, P. Stanzione, L. Brusa, M.G. Marciani, A. Siracusano, G. Bernardi, M.D. Caramia

Brief Report

Autistic-like findings associated with a urea cycle disorder in a 4-year-old girl
I. Görker, Ü. Tüzün

CCNP News and Views

The 28th Annual Meeting of the Canadian College of Neuropsychopharmacolgy

Psychopharmacology for the Clinician

Selective serotonin reuptake inhibitors (SSRIs) and depression after myocardial infarction (MI)
J.M. Le Mellédo, J. Perez-Parada

May 2005

J Psychiatry Neurosci 2005;30(3)

Editorial

Universities, governments and industry: Can the essential nature of universities survive the drive to commercialize?
S.N. Young

CCNP News and Views

2005 Award Winners; 28th Annual Meeting

Review Papers

Selective GABAergic treatment for panic? Investigations in experimental panic induction and panic disorder
P. Zwanzger, R. Rupprecht

Is the cerebellum relevant in the circuitry of neuropsychiatric disorders?
J. Z. Konarski, R.S. McIntyre, L.A. Grupp, S.H. Kennedy

Comorbidity and pathophysiology of obsessive-compulsive disorder in schizophrenia: Is there evidence for a schizo-obsessive subtype of schizophrenia?
A. Bottas, R.G. Cooke, M.A. Richter

Research Papers

Amitriptyline and fluoxetine protect PC12 cells from cell death induced by hydrogen peroxide
N. Kolla, Z. Wei, J.S. Richardson, X.M. Li

Loudness dependence of the auditory evoked potential and response to antidepressants in Chinese patients with major depression
T.W. Lee, Y.W.Y. Yu, T.J. Chen, S.J. Tsai

Psychopharmacology for the Clinician

What are the treatment options for comorbid alcohol abuse and depressive disorders?
M. Dongier

July 2005

 J Psychiatry Neurosci 2005;30(4)

Editorial

Atypical antipsychotics for mood and anxiety disorders: Safe and effective adjuncts?
P. Blier

CCNP News and Views

In memoriam — Pavel Hrdina, MD, PhD (1929-2005)
Y.D. Lapierre, G. Robertson

Review Papers

Neuropsychiatric manifestations of HIV infection and AIDS
B. Dubé, T. Benton, D.G. Cruess, D.L. Evans

Sleep and perinatal mood disorders: a critical review
L.E. Ross, B.J. Murray, M. Steiner

Chromatin, DNA methylation and neuron gene regulation — the purpose of the package
R.P. Sharma, D.R. Grayson, A. Guidotti, E. Costa

Research Papers

Responsiveness of 5-HT1A and 5-HT2 receptors in the rat orbitofrontal cortex after long-term serotonin reuptake inhibition
M. El Mansari, P. Blier

Evidence for the activity of lamotrigine at 5-HT1A receptors in the mouse forced swimming test
M. Bourin, F. Masse, M. Hascoët

Psychopharmacology for the Clinician

On the selection and use of atypical antipsychotics in the management of nonpsychotic mood and anxiety disorders
P. Blier

January 2006

J Psychiatry Neurosci 2006;31(1)

Editorial

Discontinuing treatment for psychiatric disorders
R.T. Joffe

Commentary

Ecological momentary assessment: what it is and why it is a method of the future in clinical psychopharmacology
D.S. Moskowitz, S.N. Young

Review Paper

Brain imaging and cognitive dysfunctions in Huntington’s disease
A. Montoya, B.H. Price, M. Menear, M. Lepage

Research Papers

Antipsychotic drugs cause glial cell line–derived neurotrophic factor secretion from C6 glioma cells
Z. Shao, L.E. Dyck, H. Wang, X.M. Li

Does naltrexone treatment lead to depression? Findings from a randomized controlled trial in subjects with opioid dependence
A.J. Dean, J.B. Saunders, R.T. Jones, R.M. Young, J.P. Connor, B.R. Lawford

Efficacy of methylphenidate in children with attention-deficit hyperactivity disorder and learning disabilities: a randomized crossover trial
N. Grizenko, M. Bhat, G. Schwartz, M. Ter-Stepanian, R. Joober

Psychopharmacology for the Clinician

Managing discontinuation syndrome in patients with dementia
S. Gauthier

Reviewers

2005 Reviewers

March 2006

J Psychiatry Neurosci 2006;31(2)

Editorial

Fewer classes of drugs for more and more psychiatric disorders
L.T. Young

Review Papers

Antidepressant effects of exercise: Evidence for an adult-neurogenesis hypothesis?
C. Ernst, A.K. Olson, J.P.J. Pinel, R.W. Lam, B.R. Christie

The “delayed onset” of antipsychotic action — an idea whose time has come and gone
O. Agid, P. Seeman, S. Kapur

Research Papers

Increased positive emotional memory after repetitive transcranial magnetic stimulation over the orbitofrontal cortex
D.J.L.G. Schutter, J. van Honk

Nuclear factor kappa Β in the dorsal raphe of macaques: an anatomical link for steroids, cytokines and serotonin
C.L. Bethea, A.P. Reddy, L.J. Smith

Alexithymia and stress-induced brain activation in cocaine-dependent men and women
C.S.R. Li, R. Sinha

Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis
S.H. Kennedy, H.F. Andersen, R.W. Lam

Brief Report

The use of medroxyprogesterone acetate for the treatment of sexually inappropriate behaviour in patients with dementia
S.A. Light, S. Holroyd

Psychopharmacology for the Clinician

Treatment guidelines for mania
S.H. Kennedy

September 2005

J Psychiatry Neurosci 2005;30(5)

Editorial

The Douglas Hospital Research Centre: celebrating 25 years of innovation in mental health research
R. Quirion

Douglas Hospital Research Centre Symposium

Stressed or stressed out: What is the difference?
B.S. McEwen

The Montreal Imaging Stress Task: using functional imaging to investigate the effects of perceiving and processing psychosocial stress in the human brain
K. Dedovic, R. Renwick, N. Khalili Mahani, V. Engert, S.J. Lupien, J.C. Pruessner

The Douglas Hospital Longitudinal Study of Normal and Pathological Aging: summary of findings
S.J. Lupien, G. Schwartz, Y.K. Ng, A. Fiocco, N. Wan, J.C. Pruessner, M.J. Meaney, N.P.V. Nair

Exploring the gene-environment nexus in eating disorders
C.M. Bulik

Understanding putative risk factors for schizophrenia: retropective and prospective studies
S. King, D. Laplante, R. Joober

Genetics of developmental psychiatric disorders: pathways to discovery
R. Joober, S. Sengupta, P. Boksa

Economic considerations associated with assertive community treatment and supported employment for people with severe mental illness
E. Latimer

The national policy reforms for mental health services and the story of early intervention services in the United Kingdom
R. Joseph, M. Birchwood

Psychopharmacology for the Clinician

What is the best way to treat bipolar depression?
P. Silverstone

Correction

Neuropsychiatric manifestations of HIV infection and AIDS: correction

May 2006

J Psychiatry Neurosci 2006;31(3)

Editorial

A rant against jargon and neologisms
S.N. Young

Review Papers

Schizophrenia: an integrative approach to modelling a complex disorder
G.S. Robertson, S.E. Hori, K.J. Powell

The search for new off-label indications for antidepressant, antianxiety, antipsychotic and anticonvulsant drugs
G. Chouinard

Interrelations between psychiatric symptoms and drug-induced movement disorder
G. Chouinard

Research Papers

“Missing links” in borderline personality disorder: loss of neural synchrony relates to lack of emotion regulation and impulse control
L.M. Williams, A. Sidis, E. Gordon, R.A. Meares

Downregulation in components of the mitochondrial electron transport chain in the postmortem frontal cortex of subjects with bipolar disorder
X. Sun, J.F. Wang, M. Tseng, L.T. Young

CCNP News and Views

Canadian College of Neuropsychpharmacology — 2006 Award Winners

Psychopharmacology for the Clinician

The rational use of medications in acute psychotic presentations — the case for less is more
A.G. Awad

July 2006

 J Psychiatry Neurosci 2006;31(4)

Editorial

Pregnancy, depression, antidepressants and breast-feeding
P. Blier

Review Papers

The role of neurotensin in central nervous system pathophysiology: What is the evidence?
F. St-Gelais, C. Jomphe, L.É. Trudeau

Research Papers

The effect of lithium on the adrenoceptor-mediatedsecond messenger system in the rat brain
R. Devaki, S. Shankar Rao, S.M. Nadgir

Social behaviour and mood in everyday life: the effects of tryptophan in quarrelsome individuals
M. aan het Rot, D.S. Moskowitz, G. Pinard, S.N. Young

Increased olfactory sensitivity in euthymic patients with bipolar disorder with event-related episodes compared with patients with bipolar disorder without such episodes
S. Krüger, J. Frasnelli, P. Bräunig, T. Hummel

Levomepromazine versus chlorpromazine in treatment-resistant schizophrenia: a double-blind randomized trial
S. Lal, J.X. Thavundayil, N.P.V. Nair, L. Annable, N.M.K. Ng Ying Kin, A. Gabriel, G. Schwartz

Psychopharmacology for the Clinician

Treating depression with selective norepinephrine reuptake inhibitors
P. Blier

Correction

Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis